Now showing items 1-2 of 2
A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.
OBJECTIVE: To evaluate efficacy, safety, and tolerability of laquinimod in patients with primary progressive multiple sclerosis (PPMS). METHODS: In the randomized, double-blind, placebo-controlled, phase 2 study, ARPEGGIO ...
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS.
OBJECTIVE: To evaluate the use of CSF neurofilament light chain (NfL) measurements in clinical practice as well as their effect on treatment strategies and outcomes in patients with MS. METHODS: This was an observational ...